Towards Healthcare
Ventricular Assist Device Market Climbs USD 3.38 Bn by 2034

Ventricular Assist Device (VAD) Market Size, Strategies & Competitive Analysis

Based on market forecasts, the global ventricular assist device market, projected at USD 1.7 billion in 2024, is expected to reach USD 3.38 billion by 2034, growing at a CAGR of 7.1% over the forecast period. The market is growing due to rising heart failure cases and advancements in medical technology. VADs help pump blood for patients with weakened hearts, serving as a bridge to transplant or long-term support. Key drivers include aging populations, innovation, and improved patient outcomes.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Ventricular Assist Device (VAD) Market Assessment

  • Overview
  • Global Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by Device Type (2021 – 2033)
    • LVAD
    • RVAD
    • Biventricular VAD
    • Pediatric VAD
  • Global Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Bridge to Recovery
    • Bridge to Transplant
    • Destination Therapy
    • Other Applications
  • Global Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals & ASCs
    • Specialty Clinics & Others
  • Global Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Ventricular Assist Device (VAD) Market Assessment

  • Overview
  • North America Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by Device Type (2021 – 2033)
    • LVAD
    • RVAD
    • Biventricular VAD
    • Pediatric VAD
  • North America Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Bridge to Recovery
    • Bridge to Transplant
    • Destination Therapy
    • Other Applications
  • North America Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals & ASCs
    • Specialty Clinics & Others

Europe Ventricular Assist Device (VAD) Market Assessment

  • Overview
  • Europe Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by Device Type (2021 – 2033)
    • LVAD
    • RVAD
    • Biventricular VAD
    • Pediatric VAD
  • Europe Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Bridge to Recovery
    • Bridge to Transplant
    • Destination Therapy
    • Other Applications
  • Europe Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals & ASCs
    • Specialty Clinics & Others

Asia Pacific Ventricular Assist Device (VAD) Market Assessment

  • Overview
  • Asia Pacific Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by Device Type (2021 – 2033)
    • LVAD
    • RVAD
    • Biventricular VAD
    • Pediatric VAD
  • Asia Pacific Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Bridge to Recovery
    • Bridge to Transplant
    • Destination Therapy
    • Other Applications
  • Asia Pacific Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals & ASCs
    • Specialty Clinics & Others

Middle East and Africa Ventricular Assist Device (VAD) Market Assessment

  • Overview
  • Middle East and Africa Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by Device Type (2021 – 2033)
    • LVAD
    • RVAD
    • Biventricular VAD
    • Pediatric VAD
  • Middle East and Africa Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Bridge to Recovery
    • Bridge to Transplant
    • Destination Therapy
    • Other Applications
  • Middle East and Africa Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals & ASCs
    • Specialty Clinics & Others

South America Ventricular Assist Device (VAD) Market Assessment

  • Overview
  • South America Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by Device Type (2021 – 2033)
    • LVAD
    • RVAD
    • Biventricular VAD
    • Pediatric VAD
  • South America Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Bridge to Recovery
    • Bridge to Transplant
    • Destination Therapy
    • Other Applications
  • South America Ventricular Assist Device (VAD) Market Size Value (US$) and Volume (Billion Tons), by End User (2021 – 2033)
    • Hospitals & ASCs
    • Specialty Clinics & Others

Company Profiles

  • ABIOMED
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Abbott
  • Jarvik Heart, Inc.
  • Medtronic plc
  • Berlin Heart GmbH
  • ReliantHeart Inc.
  • Abiomed Inc.
  • Cardiac Assist Inc.
  • Cirtec
  • CorWave SA
  • Fineheart

Conclusion & Recommendations

  • Insight Code: 5151
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: May 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The market is expected to experience significant growth due to rising demand and technological advancements. Focus on affordability, improved access in developing regions, and ongoing innovation will shape the future of the VAD market.

Focus on developing cost-effective VADs with extended lifespans, growing adoption of minimally invasive VAD implantation techniques, and increasing interest in destination therapy for long-term heart failure management are some of the trends.

High upfront costs of VAD devices, surgery, and long-term care, limited insurance coverage, potential out-of-pocket expenses for patients, and a shortage of skilled surgeons trained in VAD implantation procedures.

World Health Organization, National Institute of Health and American Cancer Association.